![]() |
Volumn 61, Issue 80, 2002, Pages
|
Darbepoetin alfa: A new therapeutic agent for renal anemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOHYDRATE DERIVATIVE;
DRUG ANTIBODY;
HEMOGLOBIN;
MEMBRANE RECEPTOR;
NM 279;
NM 321;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
RECOMBINANT ERYTHROPOIETIN;
UNCLASSIFIED DRUG;
ANTIBODY;
DRUG DERIVATIVE;
ERYTHROPOIETIN;
ANEMIA;
ANTIBODY DETECTION;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG STABILITY;
DRUG STRUCTURE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
NONHUMAN;
PERITONEAL DIALYSIS;
PRIORITY JOURNAL;
RENAL ANEMIA;
SIDE EFFECT;
STRUCTURE ACTIVITY RELATION;
TITRIMETRY;
TREATMENT OUTCOME;
ANIMAL;
CHRONIC KIDNEY FAILURE;
DRUG SCREENING;
IMMUNOLOGY;
REVIEW;
ANEMIA;
ANIMALS;
ANTIBODIES;
DRUG EVALUATION, PRECLINICAL;
ERYTHROPOIETIN;
HUMANS;
KIDNEY FAILURE, CHRONIC;
|
EID: 0035999924
PISSN: 00986577
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1523-1755.61.s80.11.x Document Type: Conference Paper |
Times cited : (41)
|
References (16)
|